1. Home
  2. DRTS vs MCS Comparison

DRTS vs MCS Comparison

Compare DRTS & MCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$10.03

Market Cap

641.6M

Sector

Health Care

ML Signal

HOLD

Logo Marcus Corporation (The)

MCS

Marcus Corporation (The)

HOLD

Current Price

$17.94

Market Cap

541.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
MCS
Founded
2015
1935
Country
Israel
United States
Employees
121
N/A
Industry
Medical/Dental Instruments
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
641.6M
541.6M
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
DRTS
MCS
Price
$10.03
$17.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$8.67
$23.33
AVG Volume (30 Days)
698.4K
118.2K
Earning Date
05-18-2026
04-30-2026
Dividend Yield
N/A
1.69%
EPS Growth
N/A
N/A
EPS
N/A
0.77
Revenue
N/A
$758,458,000.00
Revenue This Year
N/A
$12.05
Revenue Next Year
$699.98
$3.15
P/E Ratio
N/A
$22.49
Revenue Growth
N/A
3.11
52 Week Low
$2.81
$12.85
52 Week High
$10.81
$20.02

Technical Indicators

Market Signals
Indicator
DRTS
MCS
Relative Strength Index (RSI) 64.43 49.33
Support Level $6.59 $14.87
Resistance Level N/A $17.92
Average True Range (ATR) 0.84 0.64
MACD 0.22 -0.11
Stochastic Oscillator 78.69 39.02

Price Performance

Historical Comparison
DRTS
MCS

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About MCS Marcus Corporation (The)

Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.

Share on Social Networks: